shutterstock_82806616

Bioxodes, a clinical stage biopharmaceutical company developing novel therapies for the prevention and treatment of thrombotic and inflammatory diseases, has received Orphan Drug Designation...

Edinburgh-based biotech company Lentitek has secured £700,000 in private funding from Equity Gap, a Scottish angel investment syndicate, bringing its total investment to £1...

Medigene and EpimAb Biotherapeutics have entered a strategic co-development agreement to research and develop off-the-shelf T cell receptor (TCR)-guided T Cell Engagers (TCR-TCEs) for...